Drug:
Reaction: URINARY TRACT INFECTION
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26870987 |
1 | ||
Urinary tract infection, |
||||
ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 502 | 26871130 |
TR |
70 | 2 |
Neutropenia, Thrombophlebitis, Leukopenia, Thrombocytopenia, Hypokalaemia, Dermatitis acneiform, Anaemia, Lymphopenia, Constipation, Stomatitis, Urinary tract infection, Hyperphosphataemia, |
||||
BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, AMLODIPINE BESYLATE, CYANOCOBALAMIN, FOLIC ACID, FAMOTIDINE, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, GRANISETRON, GRANISETRON HYDROCHLORIDE, GRANISETRON, GRANISETRON HYDROCHLORIDE, GRANISETRON, GRANISETRON HYDROCHLORIDE, GRANISETRON, GRANISETRON HYDROCHLORIDE, GRANISETRON, GRANISETRON HYDROCHLORIDE, |
||||
| 503 | 26871180 |
91 | 1 | |
Oliguria, Urinary tract infection, Suspected off label use, |
||||
FINERENONE, |
||||
| 504 | 26872017 |
US |
81 | 2 |
Pulmonary oedema, Lung disorder, Urinary tract infection, Pruritus, Skin exfoliation, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, CEFPODOXIME PROXETIL, CETIRIZINE HCL, CETIRIZINE, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PREDNISONE, GUSELKUMAB, SPIRONOLACTONE, TORSEMIDE, |
||||
| 505 | 26872070 |
US |
55 | |
Hypogammaglobulinaemia, Urinary tract infection, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 506 | 26872528 |
US |
23 | 1 |
Urinary tract infection, Gastrointestinal disorder, |
||||
| 507 | 26872562 |
US |
90 | 2 |
Urinary tract infection, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 508 | 26878057 |
71 | 2 | |
Sepsis, Lactic acidosis, Urinary tract infection, Pyelonephritis, |
||||
LENALIDOMIDE, |
||||
| 509 | 26884877 |
65 | 2 | |
Urinary tract infection, Clostridium difficile infection, Therapy interrupted, |
||||
SOTATERCEPT-CSRK, TREPROSTINIL, |
||||
| 510 | 26885105 |
65 | 2 | |
Therapy interrupted, Urinary tract infection, Clostridium difficile infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TREPROSTINIL, SOTATERCEPT-CSRK, |
||||
| 511 | 26862624 |
JP |
2 | |
Chronic kidney disease, Dyspnoea, Urinary tract infection, Hypertonic bladder, Pollakiuria, Pruritus, Faecal occult blood positive, White blood cell disorder, Treatment noncompliance, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 512 | 26862643 |
US |
56 | 1 |
Clostridium difficile infection, Left ventricular hypertrophy, Seizure, Mitral valve calcification, Renal impairment, Food refusal, Product prescribing issue, Fatigue, Pain, Therapy interrupted, Somnolence, Dehydration, Chest pain, Decreased appetite, Influenza, Blood potassium decreased, Cough, Malaise, Nasopharyngitis, Urinary tract infection, White blood cell count increased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 513 | 26862724 |
US |
||
Urinary tract infection, |
||||
ESTRADIOL, |
||||
| 514 | 26862829 |
US |
37 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 515 | 26862858 |
US |
70 | 2 |
Urinary tract infection, Nasal polyps, |
||||
DUPILUMAB, |
||||
| 516 | 26863029 |
JP |
66 | 2 |
Muscle spasms, Deep vein thrombosis, Fibula fracture, Urinary tract infection, Urinary tract infection, Urinary tract infection, Urinary tract infection, Urinary tract infection, Cystitis, Cystitis, Off label use, Off label use, |
||||
INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, INEBILIZUMAB, AZATHIOPRINE, AZATHIOPRINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LUBIPROSTONE, LUBIPROSTONE, TIZANIDINE, ATORVASTATIN CALCIUM, RABEPRAZOLE SODIUM, RABEPRAZOLE, SITAGLIPTIN, ROSUVASTATIN, EZETIMIBE, CARBAMAZEPINE, CARBAMAZEPINE, CLONAZEPAM, CLONAZEPAM, |
||||
| 517 | 26863116 |
CA |
57 | 2 |
Nasal congestion, Peripheral swelling, Illness, Nasal mucosal discolouration, Respiratory tract congestion, Urinary tract infection, Tenosynovitis, Bladder disorder, Sinusitis, Arthritis, Asthma, Cough, Pain in extremity, Drug hypersensitivity, Inappropriate schedule of product administration, Pain, Weight decreased, Weight increased, |
||||
METHOTREXATE, METHOTREXATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, GLYCOPYRROLATE, OMALIZUMAB, CICLESONIDE, CICLESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 518 | 26863914 |
CA |
58 | |
Fall, Shoulder fracture, Urinary tract infection, Pneumonia, Fungal infection, |
||||
INFLIXIMAB-DYYB, |
||||
| 519 | 26864397 |
CN |
||
Pneumonia, Urinary tract infection, Herpes zoster, Hepatic function abnormal, |
||||
RITUXIMAB, |
||||
| 520 | 26864567 |
US |
46 | 2 |
Lupus nephritis, Pulmonary embolism, Infection, Renal pain, Urinary tract infection, Proteinuria, Glomerular filtration rate decreased, Hypotension, Myalgia, Gait inability, Burning sensation, Pain in extremity, Blood cholesterol increased, Therapy interrupted, |
||||
VOCLOSPORIN, VOCLOSPORIN, LOSARTAN, |
||||
| 521 | 26864988 |
US |
79 | 2 |
Urinary tract infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 522 | 26865509 |
US |
2 | |
Vulvovaginal dryness, Urinary tract infection, Blood pH decreased, Uterine pain, Product odour abnormal, |
||||
CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, |
||||
| 523 | 26865619 |
EU |
51 | 2 |
Neutropenia, Leukopenia, Glomerular filtration rate decreased, Basophil count increased, Monocyte count increased, Red cell distribution width increased, Platelet count decreased, Micturition urgency, Bladder discomfort, Eosinophil count decreased, White blood cell count decreased, Neutrophil count decreased, Lymphocyte count decreased, Lymphopenia, Haemoglobin decreased, Urinary tract infection, Red blood cell count decreased, Haematocrit decreased, Bilirubin conjugated increased, Alanine aminotransferase decreased, Aspartate aminotransferase increased, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, |
||||
| 524 | 26865729 |
60 | ||
Urinary tract infection, Off label use, |
||||
RUXOLITINIB, TOCILIZUMAB, |
||||
| 525 | 26865873 |
PR |
66 | 2 |
Urinary tract infection, Pancreatitis, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 526 | 26866621 |
CA |
2 | |
Pain in extremity, Lower respiratory tract infection, Urinary tract infection, Influenza, Gait disturbance, Pharyngitis streptococcal, Arthralgia, Memory impairment, Polymyalgia rheumatica, |
||||
OCRELIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, NABILONE, |
||||
| 527 | 26866882 |
KR |
64 | 2 |
Abscess, Nocardiosis, Brain abscess, Seizure, Seizure, Seizure, Nasopharyngitis, Productive cough, Cough, Urinary tract infection, |
||||
AVACOPAN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, GATIFLOXACIN, TENOFOVIR ALAFENAMIDE, TRANEXAMIC ACID, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, CEFTAZIDIME, ERTAPENEM SODIUM, INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN LISPRO, INSULIN DEGLUDEC, CARVEDILOL, LINAGLIPTIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, LEVETIRACETAM, LEVETIRACETAM, |
||||
| 528 | 26867131 |
US |
1 | |
Lymphoproliferative disorder, Pneumoperitoneum, Immune-mediated enterocolitis, Hypogammaglobulinaemia, Lumbar radiculopathy, Urinary tract infection, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 529 | 26867182 |
US |
67 | |
Nephrolithiasis, Urinary tract infection, Fatigue, Pain, Injection site pain, Dysgeusia, Nasopharyngitis, Pyrexia, Unevaluable event, Product dose omission issue, Inappropriate schedule of product administration, Injection site bruising, Anger, Injection site induration, Injection site discolouration, Cough, Oropharyngeal pain, Dyspnoea, Throat irritation, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, VITAMIN C, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PANTOPRAZOLE SODIUM, SERTRALINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ROSUVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, DIAZEPAM, ERGOCALCIFEROL, AMITRIPTYLINE HYDROCHLORIDE, EPLERENONE, GABAPENTIN, DIGOXIN, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 530 | 26867191 |
US |
78 | |
Urinary tract infection, Anosmia, Decreased appetite, Adverse event, Oropharyngeal pain, Headache, Cough, Nausea, Chest discomfort, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUSPIRONE HYDROCHLORIDE, CARVEDILOL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, THIAMINE HYDROCHLORIDE, MELATONIN, EMPAGLIFLOZIN, TADALAFIL, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GABAPENTIN, ESCITALOPRAM, PIRFENIDONE, OXYGEN, 0XYGEN, TIZANIDINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, ONDANSETRON HYDROCHLORIDE, TORSEMIDE, |
||||
| 531 | 26867556 |
2 | ||
Cystitis interstitial, Urinary tract infection, Inflammation, Swelling, Poor quality sleep, Hypersensitivity, |
||||
REPOSITORY CORTICOTROPIN, TOCILIZUMAB, ABATACEPT, |
||||
| 532 | 26867597 |
US |
75 | 2 |
Glycosylated haemoglobin increased, Urinary tract infection, Sleep deficit, |
||||
EMPAGLIFLOZIN, |
||||
| 533 | 26867624 |
US |
60 | 2 |
Multiple sclerosis relapse, Respiratory syncytial virus infection, Urinary tract infection, |
||||
DIROXIMEL FUMARATE, |
||||
| 534 | 26867727 |
US |
77 | 2 |
Dysphagia, Vomiting, Blood pressure increased, Urinary tract infection, Sensation of foreign body, Blood glucose increased, Dizziness, Stomatitis, Weight decreased, Decreased appetite, Constipation, Anxiety, Insomnia, Dyspnoea, Off label use, |
||||
CABOZANTINIB, NIVOLUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, TIZANIDINE HYDROCHLORIDE, ESZOPICLONE, GABAPENTIN, HUMAN INSULIN, CARVEDILOL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACARBOSE, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 535 | 26867881 |
US |
2 | |
Urinary tract infection, Muscle spasms, |
||||
OCRELIZUMAB, |
||||
| 536 | 26870301 |
69 | 1 | |
Urinary tract infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PROPRANOLOL HYDROCHLORIDE, VALSARTAN, VALSARTAN ORAL, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 537 | 26870745 |
2 | ||
Urinary tract infection, |
||||
AMBRISENTAN, |
||||
| 538 | 26857599 |
CA |
67 | |
Nephrolithiasis, Paraesthesia, Headache, Bronchitis, Diarrhoea, Urinary tract infection, |
||||
USTEKINUMAB, USTEKINUMAB, USTEKINUMAB-STBA, |
||||
| 539 | 26857952 |
AE |
84 | 2 |
Urinary tract infection, Inflammation, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 540 | 26858576 |
US |
2 | |
Status epilepticus, Loss of consciousness, Product dose omission issue, Constipation, Off label use, Urinary tract infection, Appetite disorder, Confusional state, Nephrolithiasis, |
||||
| 541 | 26858622 |
US |
79 | 2 |
Sepsis, Arteritis, Urinary tract infection, Treatment noncompliance, Dehydration, Loss of personal independence in daily activities, |
||||
UPADACITINIB, UPADACITINIB, PREDNISONE, |
||||
| 542 | 26858626 |
EU |
2 | |
Urinary tract infection, Respiratory tract infection, Blood immunoglobulin M decreased, |
||||
OFATUMUMAB, |
||||
| 543 | 26858769 |
CN |
58 | 2 |
Myelosuppression, Urinary tract infection, Septic shock, Escherichia infection, |
||||
CISPLATIN, ETOPOSIDE, |
||||
| 544 | 26858817 |
US |
77 | 2 |
Cholesteatoma, Malignant melanoma, Melaena, Conductive deafness, Sinus node dysfunction, Postmenopausal haemorrhage, Nephrolithiasis, Thoracic vertebral fracture, Rickets, Splenic infarction, Cervical spinal stenosis, Tympanosclerosis, Back pain, Peripheral vascular disorder, Palpitations, Aortic dilatation, Oesophagitis, Gastritis, Urinary tract infection, Spinal osteoarthritis, Intervertebral disc displacement, Intervertebral disc degeneration, Sacroiliitis, Chondropathy, Osteoarthritis, Bursitis, Lumbar spinal stenosis, Chronic fatigue syndrome, Mixed incontinence, Breast calcifications, Haematuria, Pollakiuria, Kyphoscoliosis, Otitis media, Lumbosacral radiculopathy, Pain, Breast pain, Flank pain, Vitamin B complex deficiency, |
||||
DENOSUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, CARVEDILOL, FAMOTIDINE, GABAPENTIN, EMPAGLIFLOZIN, LISINOPRIL, CLOPIDOGREL, RABEPRAZOLE, SPIRONOLACTONE, TERIPARATIDE, |
||||
| 545 | 26858856 |
EU |
55 | 1 |
Liver function test increased, Hypogammaglobulinaemia, Urinary tract infection, Urinary tract infection, |
||||
OCRELIZUMAB, OCRELIZUMAB, AMANTADINE, BACLOFEN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, VALSARTAN, VALSARTAN ORAL, CANDESARTAN CILEXETIL, DALFAMPRIDINE, HYDROCHLOROTHIAZIDE, |
||||
| 546 | 26859153 |
CA |
82 | 2 |
Febrile neutropenia, Pneumonia, Septic shock, Urinary tract infection, Superinfection, |
||||
METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, MOMETASONE FUROATE, MOMETASONE, ALBUTEROL SULFATE, ALBUTEROL, SPIRONOLACTONE, PREGABALIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FUROSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE, MIRABEGRON, PROCHLORPERAZINE, LORAZEPAM, |
||||
| 547 | 26859555 |
EU |
65 | 2 |
Pneumonitis, Upper respiratory tract infection, Urinary tract infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, LENALIDOMIDE, |
||||
| 548 | 26859598 |
GB |
||
Infection, Urinary tract infection, |
||||
PIRFENIDONE, |
||||
| 549 | 26859730 |
US |
2 | |
Bladder pain, Urinary tract infection, |
||||
CAPIVASERTIB, |
||||
| 550 | 26859979 |
US |
2 | |
Urinary tract infection, Oropharyngeal pain, Discomfort, Weight decreased, Dry mouth, Diarrhoea, |
||||
DENOSUMAB, |
||||
| 551 | 26860257 |
US |
57 | 2 |
Urinary tract infection, Blood urine present, Dysuria, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 552 | 26860642 |
US |
34 | 2 |
Dysphagia, Chest pain, Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 553 | 26860915 |
JP |
8 | 1 |
Electrocardiogram QT prolonged, Serous retinal detachment, Urinary tract infection, Creatine kinase increased, Wrong technique in product usage process, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 554 | 26861002 |
1 | ||
Urinary tract infection, |
||||
| 555 | 26861109 |
US |
56 | 2 |
Urinary tract infection, Injection site erythema, Injection site swelling, Inappropriate schedule of product administration, |
||||
| 556 | 26861660 |
US |
75 | 2 |
Atrial fibrillation, Urinary tract infection, |
||||
OSIMERTINIB, |
||||
| 557 | 26861839 |
UY |
65 | 2 |
Cerebrovascular accident, Urinary tract infection, Gait disturbance, Cerebrovascular accident, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 558 | 26861925 |
IN |
1 | |
Abdominal sepsis, Acute kidney injury, Kidney infection, Congenital cystic kidney disease, Haemorrhagic hepatic cyst, Pneumonia klebsiella, Toxicity to various agents, Kidney enlargement, Constipation, Urinary tract infection, Blood creatinine increased, Electrolyte imbalance, BK virus infection, Abdominal distension, Abdominal pain, Hypoalbuminaemia, Product prescribing issue, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENOLIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 559 | 26861993 |
CA |
31 | 2 |
Anxiety disorder, Headache, Paraesthesia, Dyspnoea, Rhinorrhoea, Malaise, Nasal congestion, Condition aggravated, Depression, Weight increased, Carbon monoxide poisoning, Sensitivity to weather change, Arthralgia, Lower respiratory tract infection, Fatigue, Bed bug infestation, Off label use, Arthropod bite, Heart rate increased, Product dose omission issue, Urinary tract infection, Stress, Weight decreased, Erythema, Cough, Rash, Nausea, Cystitis, Blood pressure systolic increased, Vaginal haemorrhage, Pain in extremity, Suicide attempt, Respiratory fume inhalation disorder, Body temperature increased, Pain, Urticaria, Irritable bowel syndrome, COVID-19, Pruritus, Borderline personality disorder, Mental disorder, Overdose, Mobility decreased, Breast mass, Limb discomfort, |
||||
QUETIAPINE, QUETIAPINE, QUETIAPINE, LORATADINE, LORATADINE TABLET, GABAPENTIN, RABEPRAZOLE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 560 | 26862333 |
US |
||
Constipation, Urinary tract infection, |
||||
NERANDOMILAST, NINTEDANIB, |
||||
| 561 | 26862472 |
US |
85 | 2 |
Urinary tract infection, Hydronephrosis, Chronic kidney disease, Rheumatoid arthritis, Waldenstrom^s macroglobulinaemia, Hypokalaemia, Deafness neurosensory, Nephrogenic anaemia, Hyperlipidaemia, Cystocele, Rectocele, Hypercalcaemia, Osteoarthritis, Obesity, Urinary incontinence, Bladder neoplasm, Essential hypertension, Mobility decreased, Vesicoureteric reflux, Glucose tolerance impaired, |
||||
DENOSUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CINACALCET, FAMOTIDINE, FUROSEMIDE, LOSARTAN, METHENAMINE HIPPURATE, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, AMLODIPINE, FUROSEMIDE, |
||||
| 562 | 26862486 |
CH |
70 | 2 |
Urinary tract infection, Asthenia, Pain in extremity, |
||||
| 563 | 26862491 |
US |
2 | |
Urinary tract infection, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 564 | 26862541 |
US |
48 | |
Tendonitis, Myocardial infarction, Sexual transmission of infection, Chest pain, Cellulitis, Balanitis candida, Urinary tract infection, Vaginal infection, Arthralgia, Gastrooesophageal reflux disease, Abdominal pain, Abdominal pain lower, Major depression, Traumatic arthropathy, Vaginal disorder, Proteinuria, Visual impairment, |
||||
INSULIN ASPART, |
||||
| 565 | 26864719 |
89 | 1 | |
Septic shock, Pneumonia bacterial, Staphylococcal bacteraemia, Urinary tract infection, Escherichia infection, |
||||
LENALIDOMIDE, |
||||
| 566 | 26865738 |
81 | 2 | |
Urinary tract infection, Kidney infection, Squamous cell carcinoma, Renal cyst, Drug effect less than expected, |
||||
ABATACEPT, |
||||
| 567 | 26852288 |
CO |
60 | |
Fluid retention, Peripheral swelling, Dizziness, Hyperglycaemia, Urinary tract infection, Musculoskeletal stiffness, Hypotension, Condition aggravated, |
||||
INSULIN DEGLUDEC AND LIRAGLUTIDE, LOSARTAN, |
||||
| 568 | 26852436 |
CA |
71 | 2 |
Urinary tract infection, Hypophagia, Fear, Dermatitis contact, Catheter site nodule, Catheter site bruise, Catheter site related reaction, Anxiety, Fine motor skill dysfunction, Posture abnormal, Tremor, Freezing phenomenon, Device issue, Infusion site nodule, Infusion site discomfort, Infusion site erythema, Infusion site mass, Infusion site reaction, Memory impairment, Fatigue, Confusional state, Brain fog, Aphasia, Poor quality sleep, Dyskinesia, Incorrect dose administered, Catheter site haemorrhage, Catheter site irritation, Catheter site discharge, Decreased activity, Abulia, Stress, Infusion site induration, Delirium, Weight decreased, Slow speech, Thinking abnormal, Mental disorder, Fluid intake reduced, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ENTACAPONE, MIRABEGRON, ERGOCALCIFEROL, FISH OIL, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 569 | 26852683 |
SA |
2 | |
Pulmonary oedema, Pyrexia, Fatigue, Arthralgia, Pain in extremity, Back pain, Blood cholesterol increased, Memory impairment, Diabetes mellitus, Hallucination, Bone pain, Dizziness postural, Balance disorder, Influenza, Gait inability, Malaise, Pain, Nervous system disorder, Sleep disorder, Ear pain, Dizziness, Urinary tract infection, Blood creatinine increased, Glycosylated haemoglobin increased, Blood glucose increased, Blood triglycerides increased, Otitis media, Intervertebral disc disorder, Blood sodium decreased, Incorrect product administration duration, Inappropriate schedule of product administration, |
||||
INCLISIRAN, |
||||
| 570 | 26852864 |
US |
44 | 2 |
Kidney infection, Urinary tract infection, Cystitis, Haematological infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 571 | 26852962 |
US |
54 | |
Bronchitis, Urinary tract infection, Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 572 | 26853010 |
US |
85 | 2 |
Urinary tract infection, Urinary incontinence, Illness, Feeling abnormal, Feeling jittery, Diarrhoea, Nausea, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 573 | 26853041 |
US |
2 | |
Urinary tract infection, |
||||
BELIMUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROXYCHLOROQUINE, |
||||
| 574 | 26853042 |
US |
69 | 2 |
Nephrolithiasis, Urinary tract infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 575 | 26853669 |
US |
80 | 1 |
Urinary tract infection, Weight loss poor, Influenza, Incorrect route of product administration, Dehydration, Ill-defined disorder, |
||||
| 576 | 26853696 |
US |
30 | 2 |
Hyperhidrosis, Rash, Heavy menstrual bleeding, Urinary tract infection, Muscle spasms, Muscle contractions involuntary, |
||||
LEVONORGESTREL, |
||||
| 577 | 26854013 |
SG |
40 | 2 |
Malignant neoplasm progression, Urinary tract infection, |
||||
ATEZOLIZUMAB, |
||||
| 578 | 26854221 |
MX |
59 | 2 |
Hypertension, Urinary tract infection, Pancreatitis, Helicobacter gastritis, Renal failure, Diabetes mellitus, Influenza, Septic shock, Mental disorder, Hyperhidrosis, Secretion discharge, Product use issue, Cough, Chest discomfort, Duodenitis, Drug ineffective, Blood pressure increased, |
||||
FLUTICASONE PROPIONATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, |
||||
| 579 | 26854260 |
CO |
85 | 2 |
Death, Product dispensing issue, Eating disorder, Speech disorder, Pneumonia, Muscle rigidity, Urinary tract infection, Off label use, |
||||
| 580 | 26854330 |
US |
84 | 1 |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, ENTACAPONE, DONEPEZIL HYDROCHLORIDE, LORAZEPAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 581 | 26854331 |
CA |
76 | 1 |
Urinary tract infection, Nephrolithiasis, Myocardial infarction, Urosepsis, Renal impairment, Aortic aneurysm, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 582 | 26854410 |
US |
59 | 1 |
Pyrexia, Abdominal pain, Pain, Nocturia, Chills, Diarrhoea, Nausea, Eating disorder, Urinary tract infection, Feeling abnormal, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 583 | 26854606 |
US |
73 | 1 |
Alopecia, Urinary tract infection, Hypertension, Flushing, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 584 | 26855164 |
PR |
68 | 2 |
Decubitus ulcer, Urinary tract infection, Administration site mass, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 585 | 26855372 |
56 | 2 | |
Pneumonia, Urinary tract infection, Human rhinovirus test positive, Cardiomegaly, Pericardial effusion, |
||||
| 586 | 26855874 |
JP |
2 | |
Death, Cellulitis, Malignant neoplasm progression, Urinary tract infection, Adrenal insufficiency, Hypothyroidism, Hypertension, Hyponatraemia, Myelosuppression, Infection, Pyelonephritis, |
||||
PEMBROLIZUMAB, |
||||
| 587 | 26856104 |
2 | ||
Urinary tract infection, Therapy interrupted, |
||||
BELZUTIFAN, |
||||
| 588 | 26856123 |
2 | ||
Dehydration, Urinary tract infection, |
||||
NIRAPARIB, |
||||
| 589 | 26856413 |
US |
2 | |
Urinary tract infection, Blood disorder, Disease progression, Meningitis, Renal impairment, |
||||
RAVULIZUMAB, |
||||
| 590 | 26856496 |
|||
Product quality issue, Fungal infection, Urinary tract infection, |
||||
EMPAGLIFLOZIN, |
||||
| 591 | 26856554 |
CN |
68 | 1 |
Candida infection, Urinary tract infection, |
||||
ERTUGLIFLOZIN, |
||||
| 592 | 26856952 |
US |
64 | |
Urinary tract infection, Aphonia, |
||||
RELACORILANT, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BEVACIZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXTROSE MONOHYDRATE, DEXTROSE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, PANTOPRAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PROCHLORPERAZINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 593 | 26857002 |
US |
21 | 2 |
Hypervolaemia, Oedema, Urinary tract infection, Urinary retention, White blood cell count abnormal, Blood pressure increased, Lethargy, Somnolence, Fibrin D dimer increased, Heart rate abnormal, Oedema peripheral, Dyspnoea, |
||||
ELOSULFASE ALFA, |
||||
| 594 | 26857184 |
US |
66 | 2 |
Dyspnoea, Psoriasis, Dizziness, Eye infection, Feeling hot, Nasopharyngitis, Herpes virus infection, Speech disorder, Sitting disability, Urinary tract infection, Oropharyngeal pain, Asthenia, Eye irritation, Anxiety, Infection, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 595 | 26857305 |
US |
54 | 2 |
Sepsis, Urinary tract infection, Parkinson^s disease, Nephrolithiasis, Asthenia, Blood glucose increased, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 596 | 26859861 |
|||
Feeling abnormal, Abdominal pain upper, Hypophagia, Urinary tract infection, Motor dysfunction, Cognitive disorder, Altered state of consciousness, Aphasia, Renal pain, Diarrhoea, |
||||
SECUKINUMAB, |
||||
| 597 | 26860230 |
79 | 2 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 598 | 26846762 |
TW |
57 | 2 |
Sepsis, Pyelonephritis acute, Urinary tract infection, |
||||
EMPAGLIFLOZIN, |
||||
| 599 | 26846933 |
EU |
2 | |
Diverticulitis, Waldenstrom^s macroglobulinaemia, Bacteraemia, Urinary tract infection, Drug effective for unapproved indication, Off label use, |
||||
ECULIZUMAB, ECULIZUMAB, |
||||
| 600 | 26846968 |
CA |
26 | |
Crohn^s disease, Abdominal distension, Lung disorder, Abdominal discomfort, Abdominal pain, Disseminated tuberculosis, Intentional dose omission, Decreased appetite, Condition aggravated, Anal fissure, Harvey-Bradshaw index increased, Weight decreased, Vomiting, Cough, Sputum discoloured, Abdominal pain upper, Nausea, Fatigue, Pain, Pyrexia, Weight increased, Urinary tract infection, Helicobacter infection, Infection, Therapy interrupted, Off label use, Underdose, Therapy partial responder, Therapeutic response shortened, Product availability issue, Inappropriate schedule of product administration, Product dose omission issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30